Flagship Harbor Advisors, LLC Immucell Corp Transaction History

Flagship Harbor Advisors, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 13, 2023	SELL	$6.09 - $8.25 $12,180 - $16,500	-2,000 Reduced 12.32%	14,230 $0
Q1 2022 Apr 13, 2022	SELL	$8.0 - $10.06 $4,000 - $5,030	-500 Reduced 2.99%	16,230 $157,000
Q4 2021 Feb 10, 2022	SELL	$8.0 - $9.74 $8,000 - $9,740	-1,000 Reduced 5.64%	16,730 $134,000
Q2 2021 Jul 26, 2021	BUY	$8.5 - $10.95 $27,030 - $34,821	3,180 Added 21.86%	17,730 $168,000
Q1 2021 May 03, 2021	BUY	$5.98 - $11.88 $15,249 - $30,294	2,550 Added 21.25%	14,550 $140,000
Q3 2020 Oct 13, 2020	SELL	$4.98 - $6.35 $1,942 - $2,476	-390 Reduced 3.15%	12,000 $65,000
Q2 2020 Jul 31, 2020	BUY	$3.95 - $4.9 $48,940 - $60,711	12,390 New	12,390 $58,000
Q4 2019 Feb 14, 2020	SELL	$4.81 - $5.57 $14,429 - $16,710	-3,000 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$6.75 - $8.28 $20,250 - $24,839	3,000 New	3,000 $20,000

1.15M

Ticker ICCC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 7,746,860
Market Cap $40.6M
Description
ImmuCell Corporation, an animal health company, develops, manufactures, and markets products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. It offers First Defense, an orally delivered scours preventive product for newborn dairy and beef calves; and Tri-Shield First Defense, a passive ...

Get notified when there are updates to the investment portfolio of Flagship Harbor Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Flagship Harbor Advisors, LLC with notifications on news.